BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27792904)

  • 21. The LMP2A signalosome--a therapeutic target for Epstein-Barr virus latency and associated disease.
    Portis T; Cooper L; Dennis P; Longnecker R
    Front Biosci; 2002 Feb; 7():d414-26. PubMed ID: 11815296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
    Ikeda M; Ikeda A; Longan LC; Longnecker R
    Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
    DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
    mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells.
    Lu J; Lin WH; Chen SY; Longnecker R; Tsai SC; Chen CL; Tsai CH
    J Biol Chem; 2006 Mar; 281(13):8806-14. PubMed ID: 16431925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
    Swart R; Ruf IK; Sample J; Longnecker R
    J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr virus LMP2A utilizes Syk and PI3K to activate NF-κB in B-cell lymphomas to increase MIP-1α production.
    Incrocci R; McAloon J; Montesano M; Bardahl J; Vagvala S; Stone A; Swanson-Mungerson M
    J Med Virol; 2019 May; 91(5):845-855. PubMed ID: 30609049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.
    Ikeda M; Longnecker R
    Virology; 2009 Mar; 385(1):183-91. PubMed ID: 19081591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.
    Winberg G; Matskova L; Chen F; Plant P; Rotin D; Gish G; Ingham R; Ernberg I; Pawson T
    Mol Cell Biol; 2000 Nov; 20(22):8526-35. PubMed ID: 11046148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
    Fotheringham JA; Coalson NE; Raab-Traub N
    J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
    Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
    Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
    Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
    Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
    Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
    Rovedo M; Longnecker R
    J Virol; 2007 Jan; 81(1):84-94. PubMed ID: 17035319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
    Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
    J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein.
    Matskova LV; Helmstetter C; Ingham RJ; Gish G; Lindholm CK; Ernberg I; Pawson T; Winberg G
    Oncogene; 2007 Jul; 26(34):4908-17. PubMed ID: 17311000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane-associated signaling in human B-lymphoma lines.
    Tauzin S; Ding H; Burdevet D; Borisch B; Hoessli DC
    Exp Cell Res; 2011 Jan; 317(2):151-62. PubMed ID: 20875408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of latent membrane protein 2 isoforms in Epstein-Barr virus latency.
    Rechsteiner MP; Bernasconi M; Berger C; Nadal D
    Trends Microbiol; 2008 Nov; 16(11):520-7. PubMed ID: 18835714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.
    Hatton O; Lambert SL; Phillips LK; Vaysberg M; Natkunam Y; Esquivel CO; Krams SM; Martinez OM
    Am J Transplant; 2013 Apr; 13(4):883-890. PubMed ID: 23398911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor.
    Ingham RJ; Raaijmakers J; Lim CS; Mbamalu G; Gish G; Chen F; Matskova L; Ernberg I; Winberg G; Pawson T
    J Biol Chem; 2005 Oct; 280(40):34133-42. PubMed ID: 16087662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes.
    Tomita M; Dewan MZ; Yamamoto N; Kikuchi A; Mori N
    Cancer Sci; 2009 May; 100(5):807-12. PubMed ID: 19309363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.